Top 'retail' tactics for sunwear

Article

Optometrists can learn much from three of the country's leading retailers when it comes to increasing sunwear sales.

Selling at every step

http://Amazon.com/, as anyone who has used the popular Web site knows, is very good at making offers of more sales at every point along the initial sales process. The site's hallmark is its ongoing sale pitches: "If you're buying this, you'd probably also like this," or, "Customers who bought this item also bought." The strategy is simple yet effective.

Don't limit your patient to sunwear styles that are similar to the eyeglass frames they're considering. "Show them something different from their regular eyeglass frame," Gibb said. "Sunglasses get to be the 'fun purchase.' People can go off the beaten path from the typical conservative colors or size they may typically pick out. When you add the 'this- is-fun-and-9different' element to the sunglass sale, it creates a different feeling about the purchase."

Gibb also suggested talking about sunwear during the exam, during a contact lens purchase, and during the dispensing process. Optometrists may also wish to write a separate prescription for sunwear along with the prescription for eyeglasses.

Another very effective time to suggest sunwear is during the appointment reminder. When your staff is calling patients to remind them of an upcoming appointment, have them tell the patients to be sure to bring their sunwear as well as their regular glasses. "That makes patients think, 'Oh, wait, I'm supposed to have sunwear,'" Gibb said. "It's a very subtle yet effective way of delivering the message to patients that they need to have sunwear."

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.